12695884|t|Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
12695884|a|Cognitive impairment in Alzheimer's disease (AD) is not fully explained. PET indicates reduced cerebral metabolic rate for glucose. Since glutamate neurotransmission (GNT) consumes more than 80% of the ATP generated from metabolism, a pilot study was carried out to determine the neuronal tricarboxylic acid cycle (TCA) based on the hypothesis that reduced GNT could contribute to cognitive impairment in AD. Three AD patients with cognitive impairment (mini-mental state exam: 24 vs 30, P<0.05) and significant reduction in both N-acetyl aspartate (NAA)/Creatine (Cr) ( P<0.009) and NAA/myo-inositol (mI) ratio ( P<0.01), and three age-matched controls each received 0.014-0.016 g/kg/min 99%1-13C glucose IV. Quantitative (1)H and proton-decoupled (13)C MR brain spectra were acquired from combined posterior-parietal white matter and posterior-cingulate gray matter every 5 min for 140 min.(13)C magnetic resonance spectroscopy (MRS) measures of glucose oxidation and neuronal TCA rate, including prolonged time to (13)C enrichment of glutamate (Glu2) ( P<0.004) and bicarbonate (HCO(3)) ( P<0.03) as well as reduced relative enrichment of Glu(2)/Glu(4) between 60 and 100 min ( P<0.04), were significantly different in AD patients vs. controls. (13)C measures of GNT, glutamine (Gln)(2)/Glu(2) ( P<0.02) and rates of glutamate enrichment (Glu(2)/glucose: 0.34 vs 0.86, P=ns and Glu(4)/glucose 0.26 vs 0.83, P=ns), were also reduced.(13)C MRS measures of neuronal TCA cycle, glucose oxidation and GNT were significantly correlated with measures of neuronal integrity: NAA/Cr, [NAA] and mI/NAA as determined by (1)H MRS ( R(2)=0.73-0.95; P<0.05-0.01), suggesting that impairment of GNT may be a contributing factor in the cognitive impairment characteristic of AD.
12695884	8	17	glutamate	Chemical	MESH:D018698
12695884	39	47	patients	Species	9606
12695884	53	72	Alzheimer's disease	Disease	MESH:D000544
12695884	87	92	(13)C	Chemical	MESH:C000615229
12695884	132	152	Cognitive impairment	Disease	MESH:D003072
12695884	156	175	Alzheimer's disease	Disease	MESH:D000544
12695884	177	179	AD	Disease	MESH:D000544
12695884	255	262	glucose	Chemical	MESH:D005947
12695884	270	279	glutamate	Chemical	MESH:D018698
12695884	334	337	ATP	Chemical	MESH:D000255
12695884	421	439	tricarboxylic acid	Chemical	MESH:D014233
12695884	513	533	cognitive impairment	Disease	MESH:D003072
12695884	537	539	AD	Disease	MESH:D000544
12695884	547	549	AD	Disease	MESH:D000544
12695884	550	558	patients	Species	9606
12695884	564	584	cognitive impairment	Disease	MESH:D003072
12695884	662	680	N-acetyl aspartate	Chemical	MESH:C000179
12695884	682	685	NAA	Chemical	MESH:C000179
12695884	687	695	Creatine	Chemical	MESH:D003401
12695884	697	699	Cr	Chemical	MESH:D003401
12695884	716	719	NAA	Chemical	MESH:C000179
12695884	720	732	myo-inositol	Chemical	MESH:D007294
12695884	734	736	mI	Chemical	-
12695884	825	837	-13C glucose	Chemical	-
12695884	855	859	(1)H	Chemical	-
12695884	881	886	(13)C	Chemical	MESH:C000615229
12695884	1024	1029	(13)C	Chemical	MESH:C000615229
12695884	1080	1087	glucose	Chemical	MESH:D005947
12695884	1149	1154	(13)C	Chemical	MESH:C000615229
12695884	1169	1178	glutamate	Chemical	MESH:D018698
12695884	1180	1184	Glu2	Chemical	-
12695884	1201	1212	bicarbonate	Chemical	MESH:D001639
12695884	1214	1220	HCO(3)	Chemical	MESH:D001639
12695884	1274	1277	Glu	Chemical	MESH:D018698
12695884	1281	1284	Glu	Chemical	MESH:D018698
12695884	1354	1356	AD	Disease	MESH:D000544
12695884	1357	1365	patients	Species	9606
12695884	1380	1385	(13)C	Chemical	MESH:C000615229
12695884	1403	1412	glutamine	Chemical	MESH:D005973
12695884	1414	1417	Gln	Chemical	MESH:D005973
12695884	1422	1425	Glu	Chemical	MESH:D018698
12695884	1452	1461	glutamate	Chemical	MESH:D018698
12695884	1474	1477	Glu	Chemical	MESH:D018698
12695884	1481	1488	glucose	Chemical	MESH:D005947
12695884	1513	1516	Glu	Chemical	MESH:D018698
12695884	1520	1527	glucose	Chemical	MESH:D005947
12695884	1567	1572	(13)C	Chemical	MESH:C000615229
12695884	1609	1616	glucose	Chemical	MESH:D005947
12695884	1702	1705	NAA	Chemical	MESH:C000179
12695884	1706	1708	Cr	Chemical	MESH:D003401
12695884	1711	1714	NAA	Chemical	MESH:C000179
12695884	1720	1722	mI	Chemical	-
12695884	1723	1726	NAA	Chemical	MESH:C000179
12695884	1744	1748	(1)H	Chemical	-
12695884	1855	1875	cognitive impairment	Disease	MESH:D003072
12695884	1894	1896	AD	Disease	MESH:D000544
12695884	Negative_Correlation	MESH:C000179	MESH:D003072
12695884	Association	MESH:C000615229	MESH:D005973
12695884	Association	MESH:D007294	MESH:D000544
12695884	Association	MESH:D005973	MESH:D000544
12695884	Association	MESH:D005947	MESH:D000544
12695884	Negative_Correlation	MESH:C000179	MESH:D000544
12695884	Association	MESH:D005947	MESH:D018698
12695884	Association	MESH:C000615229	MESH:D001639
12695884	Association	MESH:C000615229	MESH:D000544
12695884	Association	MESH:D018698	MESH:D000544
12695884	Association	MESH:D001639	MESH:D005947
12695884	Association	MESH:C000615229	MESH:D005947
12695884	Association	MESH:D001639	MESH:D000544
12695884	Negative_Correlation	MESH:D003401	MESH:D003072
12695884	Association	MESH:C000615229	MESH:D018698
12695884	Negative_Correlation	MESH:D003401	MESH:D000544

